FDA approved gene therapies Flashcards

(25 cards)

1
Q

why are gene therapeutic used?

A

for managing difficult to treat diseases- using nanoplexes and other carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is gene therapy?

A

Human genetic disease= result of mutation or
deletion of gene (s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the aim of gene therapy?

A

To treat the cause rather than the
symptoms of the diseases= caused by single
gene mutation or deletion (e.g. Haemophilia,
Cystic fibrosis, Muscular dystrophy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when would gene therapy be used?

A

more than one
gene affected and no clear identification of the
position (s) of the defect (e.g. cancer,
Parkinson’s & Alzheimer’s disease )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does gene therapy work?

A

Delivery of replacement or insertion gene
sequence into cell nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how may dna reach its site of action?

A

must pass a number of compartments
ie gene transfection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is DNA and RNA made up?

A

DNA= deoxyribonucleic acid, carbohydrate unit
2-D-Deoxyribose
= represents genetic material
RNA= ribonucleic acid, carbohydrate unit 2-D-
Ribose
= essential for biosynthesis of proteins
=different types; here important mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the two principle ways of gene delivery to the cell nucleus?

A

viral and non-viral vectors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the risks associated with viral vectors?

A

safety risks
high immunogenicity after repeated admin
potential oncogenicity due to mutagenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what size must dna be in viral vectors?

A

small size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do non- viral vectors work?

A

coupling on polymers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what size molecules can be carried by non-viral vectors?

A

large DNA molecules can be carried

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the benefits of non-viral vectors?

A

can be produced in large quantities easily and inexpensively
significantly lower safety risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

do non-viral vectors have a low or high transfection efficiency?

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the problematic properties of DNA?

A

*Highly charged polyelectrolyte
*Due to extra- and intracellular electrolyte concentrations stretched out
*Due to negative charge repulsive electrostatic interaction between DNA and negatively charged cell surface
*DNA size 800 nm to 10 μm
*Maximum possible size of DNA complex <1000 nm
*Carrier systems (DNA complexes)
*strong enough to protect DNA from blood plasma DNases
*weak enough to release DNA inside the target cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the problems associated with in vivo-gene delivery by cationic liposome dna complexes?

A

*Net positive charge
- when administered, for example, i.v. complexes will encounter negatively charged entities: serum proteins, lipoproteins and blood cells
- risk of flocculation and embolism
- positively charged particles are cleared from the circulation via reticuloendothelial system
*Pulmonary delivery
- encounter of lung surfactants
*Loss of positive charge leads to deterioration of transfection performance

17
Q

what is PEI?

A

Gene delivery using cationic polymers
Polyethylene imine (PEI)
*Gold standard of non viral vectors

18
Q

what are the properties of PEI?

A

*Can complex large DNA molecules
*Homogeneous spherical particles (~ 100 nm in size)
*Protection against nuclease degradation
*Fairly toxic

19
Q

what are obsticles to gene therapy?

A

immune reactions

20
Q

when is VEGR used?

A

For cardiovascular diseases
Gene therapy with VEGF has shown in
clinical trials to increase formation of new
vessels (angiogenesis) in ischaemic tissues
*Angiogenesis has therapeutic potential to
improve vascularisation in areas of
decreased blood flow caused by ischaemic
heart disease.

21
Q

what is chitosan?

A

Chitosans are biodegradable, linear amino
polysaccharides with a random distribution of b–
1,4–N–acetyl–D–glucosamine and D–
glucosamine.

22
Q

is chitosan safe?

A

They are derived from the biopolymer chitin and
are used in food preparations.
Hence, their use is safe.

23
Q

what are the properties of chitosan?

A

The polyplexes formed are stable, small and
toroidal in shape i.e. their appearance is similar
to a tyre or a hollow ring.

24
Q

how does chitosan protect DNA?

A

The DNA is entrapped in the inner cavity
and hence protected from degeneration by
DNase.

25
how does chitosan stay stable and transfect target cells?
the amount of positively charged monomer units in the polyplexes must be greater than 65%.